key: cord-0016933-2xbh2gv0 authors: Chanie, Ermias Sisay; Bayih, Wubet Alebachew; Birhan, Binyam Minuye; Belay, Demeke Mesfin; Asmare, Getnet; Tiruneh, Tegenaw; Aynalem, Yared Asmare Aynalem; Abat, Biruk Beletew; Asnakew, Sintayehu; Mekie, Maru; Yitbarek, Getache Yideg; GebreEyesus, Fisha Alebel title: Incidence of advanced opportunistic infection and its predictors among HIV infected children at Debre Tabor referral Hospital and University of Gondar Compressive specialized hospitals, Northwest Ethiopia, 2020: A multicenter retrospective follow-up study date: 2021-04-09 journal: Heliyon DOI: 10.1016/j.heliyon.2021.e06745 sha: ce414c4eed9c916e5c6e337421ce46a59ddd18e7 doc_id: 16933 cord_uid: 2xbh2gv0 BACKGROUND: This study is aimed to assess the incidence of advanced opportunistic infections (OIs) and its predictors among Human Immunodeficiency Virus (HIV) infected children at Debre Tabor referral Hospital and University of Gondar Compressive specialized Hospitals, Northwest Ethiopia, 2020. METHODS: A retrospective follow-up study was conducted from June 1, 2010, to May 30, 2020. A total of 349 children under the age of 15 who had received Anti-Retroviral Therapy (ART) were included in the study. Data were entered into Epi info version 7.2 and then exported to Stata 14.0 for analysis. Kaplan Meier curve and Log-rank test were used to determine the median survival time and the discrepancy of different categorical variables. The Cox regression model was used to identify the predictors of advanced opportunistic infections. The Adjusted hazard ratio (AHR) at 95% confidence interval (CI) was used to declare statistical significance. RESULT: The incidence rate of advanced opportunistic infection was 5.53 per 100 (95% CI: 4.7, 6.9) Person per year observation (PYO). The median survival time was 113 months and the total follow-up periods were yielding 18882 months. Children presenting with treatment failure, Cotrimoxazole Preventive Therapy (CPT) non-user, low hemoglobin level (<10 mg/dl), and poor/fair level of adherence to ART were less free survival time as compared to their counterparts for advanced opportunistic infections. CONCLUSION: In this study, the median of advanced OIs free survival time was found to be low and the incidence rate was found to be high. The incidence advanced OIs was associated with anemia, treatment failure, and poor/fair level of adherence, cotrimoxazole preventive therapy non-users. Further research should conduct to evaluate and to improve the quality of care in the study area. Opportunistic infections (OIs) are infections that occur more often or are more severe in people with weakened immune systems [1] , including people with Human Immunodeficiency Virus (HIV) [2] . In 2019, 36.2 million were adults and 1.8 million were children (<15 years old) living with HIV. The same year, there 690 000 were Acquired Immune Deficiency Syndrome (AIDS) related deaths, of which the majority can be attributed to OIs [3, 4] . Besides, advanced OIs is the major cause of disease and death in HIV infected children [5] . The hallmark of HIV infection is immunosuppression which predisposes to OIs, which contributes to morbidity and mortality in HIV infected children worldwide [5, 6, 7] . As a result, the prevention of opportunistic infections in HIV infected children is crucial [8, 9, 10] . However, OIs remain a major cause of morbidity and mortality among these vulnerable population even after Anti-Retroviral Therapy (ART) [7] . In resource-rich countries, the life expectancy of newly infected patients with HIV starting on ART has almost reached the lifespan of the general population [11, 12, 13] . However, in Sub-Saharan countries, life expectancy among HIV infected patients is far from the general population [7, 12, 14] , due to OIs [15] . Regardless of increasing access to effective HIV prevention, diagnosis, and treatment worldwide [16] , OIs are the leading causes of morbidity and mortality among HIV-infected children [17, 18] . The impact of HIV associated OIs in HIV-infected children has been well documented in advanced countries [19] , while in Sub -Saharan Africa (SSA), the true burden of OIs among HIV-children remains poorly documented [20] , and Ethiopian is one of them [5] . Despite the incidence of OIs after initiation of ART is a decline dramatically worldwide [13, 19] , they are a leading cause of poor quality of life, hospitalization, and poor adherence among HIV infected children in Ethiopia [5, 21, 22] . Besides, OIs remains a major cause of morbidity and mortality among this vulnerable population [7] , which contributes to 94.1% of HIV-related deaths [17, 18] . Advanced OIs are a life-threatening cause of morbidity and mortality associated with HIV [6] , markedly in HIV infected children [23, 24] . since their immunity is not well developed [25] . Even advanced OIs is a common cause of hospitalization and death among HIV infected children, there has been no prior evidence about the time to develop advanced opportunistic infections and its predictors among HIV infected children in Ethiopia. Therefore, this study is aimed to assess the incidence of advanced opportunistic infection and its predictors among HIV infected children at Debre Tabor referral Hospital and University of Gondar Compressive Specialized Hospital, Northwest Ethiopia, 2020. A retrospective follow-up study was conducted from June 1, 2010, to May 30, 2020, at University of Gondar Compressive specialized hospital and Debre Tabor referral hospital, Northwest Ethiopia, 2020. The first study area was University of Gondar Compressive specialized hospital pediatric ART clinic which is Gondar town, which is located in North West Ethiopia. It is far from 737 km from Addis Ababa, Ethiopia. The hospital serves about 5 million people. ART service has been started in 2005. In 2017, a total of 8581 adults and 1138 children were registered in ART clinic [26] . Besides, the second study area was Debre Tabor referral hospital which is located in Debre Tabor town and far from 665 km from Addis Ababa. The hospital serves around 3.7 million people. ART service is one of the services delivered since 2005. In 2018, a total of 9859 adults and 698 pediatrics patients have been enrolled in ART clinic [27] . All HIV infected children at Debre Tabor referral hospital and university of Gondar compressive specialized hospital, 2020. All HIV infected children from June 1, 2010, to May 30, 2020, at Debre Tabor referral hospital and University of Gondar compressive specialized hospital, 2020. Children whose age less than 15 year and followed their treatment during the study period were eligible for this study. Unrecorded of the outcome variable (i.e., advanced OI was not recorded) in the medical charts and ART follow-up database of HIV infected children were excluded. Time to develop advanced opportunistic infection: The time from children ART initiation to the occurrence of the event (i.e., advanced OIs) during the follow-up period. Advance opportunistic infection (event): They are a severe type of opportunistic infections associated with HIV [5, 23, 24] . According to the Ethiopian ART guidelines, advanced OIs include bacterial pneumonia, pulmonary TB, extra-pulmonary TB, oral candidiasis, esophageal candidiasis, and chronic diarrhea for longer than 1 month, pneumocystis pneumonia, toxoplasmosis, Cryptococci meningitis, non-Hodgkin's lymphoma, Kaposi's sarcoma, wasting syndrome and others [28, 29] . HIV infected children reference the age of the children <15 years, and they enrolled in pediatric ART clinic in Ethiopian context [30] . Censored: Children who were lost to follow-up, transferred out to another health institution, and end of the study period before developing an advanced opportunistic infection. Level of adherence to ART was classified into good, fair, or poor by the percentage of drug dosage calculated from the total monthly doses of ART drugs taking (Good >95%, fair 85-94%, poor <85%) [29] . Underweight or stunting was defined as weight for age Z-score < À2 SD for under-five children and BMI for age Z-score < À2 SD for older children [17] . Low hemoglobin level (Anemia) was defined as having a hemoglobin level <10 mg/dl [17] . Dependent variable: Time to develop advanced OIs. Independent variables: Socio-demographic characteristics: Age, sex, residence, HIV disclosure status, and religion. Moreover, marital status, educational status, occupation, life status, and HIV status of the caregiver. Clinical and Treatment-related characteristics: Weight for height, height for age, low hemoglobin level, CD4 (Cluster of Differentiation 4) counts or %, regimen at baseline, Cotrimoxazole preventive therapy (CPT), Isoniazid preventive therapy (IPT), level of adherence to ART, treatment failure, functional status, year of initiation and duration on ART. Log-rank survival data analysis of the two-population proportion formula was used to determine the sample size. Besides, the assumptions-95% Confidence Interval (CI), 80% optimum statistical power, and taking type one error 5% were taken with hemoglobin level < 10 g/dl as the exposed group denoted by q1 (0.548) and hemoglobin level !10 g/dl as the non-exposed denoted by q0 (0.7020) from a study that was conducted at Debre Markos referral hospital [17] , and the final total sample size, after adding 10% as incomplete or inconsistent data were 349. A total of 1076 children from June 1, 2010, to May 30, 2020 were selected from both hospitals since they fulfilled the inclusion criteria. By using proportional allocation, 148 and 201children were selected followed by a simple random sampling technique from Debre Tabor referral hospital and University of Gondar compressive specialized hospital, respectively ( Figure 1 ). The data was collected from the ART follow-up database and children's chart and data extraction tool was adapted from Ethiopian ART guidelines. The socio-demographic, clinical, and treatment-related variables were extracted from the ART follow-up database and medical records by five bachelor degree nurses who were familiar with the ART follow-up. The two supervisors had overseen the overall process of data collection, and the data collector and supervisors were taking basic ART training. The data extraction tool was pretested through 5% (18 medical records of the sample to check the consistency and completeness of the data items). Moreover, the data extraction tool was adopted from a standardized Ethiopian ART guidelines follow-up format. Two days of training were given on how to review ART follow-up databases and medical records plus the objective of the study for data collectors and supervisors. Besides, the data collector coded the charts to avoid duplication, and charts that didn't fulfill the inclusion criteria were excluded. Before the actual entry, data were checked for inconsistency, coding errors, completeness, accuracy, clarity, and missing values; and then entered into Epi Info 7.2 and analyzed by Stata14.0 Software. Descriptive and summary statistics were carried out using the median, mean, proportion, frequency, and interquartile ranges. Tables and figures were used to present the data. The incidence of advanced opportunistic infection was calculated by dividing the number of children developing Advanced OIs during the follow-up period by the children person-years observation. A Kaplan Meier curve was used to estimate the overall median survival time. In addition to this, the Kaplan Meier curve was used to determine the median survival time with respect to different categories. A Log-rank test was used to see the discrepancy between the predictor variables along with the p-value. COX proportional hazard model assumption and goodness of fitness were checked through the Schoenfeld residual (global test ¼ 0.95800) and stphplot-Log-Log parallel plot of survival respectively. Moreover, the Cox proportional hazard model was fitted both bivariable and multivariable to identify predictors of advanced OIs. The variables having a p-value up to 0.25 in the bivariable analysis were entered into the multivariable model to declare a significant variable. Adjusted Hazard ratio (AHR) with 95% confidence interval was used to explain the strength of the association, and variables with P-value less than 0.05 in the multivariable analysis were considered as significantly associated with the dependent variable. Ethical considerations: Ethical approval was obtained from Debre Tabor University ethical review committee. Besides, permission letters from Debre Tabor referral hospital and University of Gondar compressive specialized hospital were obtained from ART focal person. Name or identification numbers of children were not allowed to record in the data extraction tool, rather grouping analysis was carried out to ensure the confidentiality of the study participants. Of the 349 participants, 180 (51.6%) were male with a mean AE SD age of 7.33 AE 0.178 years; 188 (53.9%) of the participants were between 5-9 years of age. Fifty-one percent of children knew their HIV status, and 68.5% of their caregivers were alive. 54.2% and 77.7% of child caregivers were none employed and HIV positive respectively. Moreover, the majority of the caregivers (79.91%) were rural residences, 67.0% were married, and 85.1% were orthodox Christian in the follow-up period ( Table 1) . The majority (84%) of the children were hemoglobin level ! 10 mg/ dl and two-thirds (63.0) of the children were initiated ART after the year 2014. About 80.2% of children had CD4 counts or % above the threshold level, 86.5% of children were Zidovudine containing regimen. Almost half (51. %) of the children were underweight and 41.0% of the children were stunted. Besides, 78.5% and 28.7 % of children were CPT and IPT users respectively. The majority, 91.7% and 76.8 % of children were appropriate functional status and a good level of ART adherence respectively. 41. % of children were taking ART more than 59 months, whereas 12.6 % had treatment failure ( Table 2) . The cumulative probability of survival of advanced OIs was found to be 24.9% [CI: 23.2-29.5]. Besides, the incidence rate of advanced OIs was found to be 5.53 per 100 PYO (95% CI: 4.7, 6.9). Pneumonia was the most common complaint seen in 35.6% of the children followed by tuberculosis (28.7%), oral candidiasis (10.3 %), esophageal candidiasis (4.6%), wasting syndrome (5.8%), chronic diarrhea greater than 01 months (10.3%), and others (16%) (Figure 2 ). In this study, the median advanced OIs free survival time was 113 months (IQR ¼ 65,161). In addition to this, the total follow-up period yields were 18882 months or 1573.5 years (figure). The advanced OIs free survival probability of children at the end was 0.75 [95% CI: 0.72-0.70] follow-up period (Figure 3) . The Figure 4 ). Residence, marital status of the caregivers, hemoglobin level, weight for age, taking CPT prophylaxis, treatment failure, and level of adherence to ART adherence were variables entered into the multivariable analysis. Of these, treatment failure, CPT non-users, low hemoglobin level, and poor/fair level of adherence to ART were found to be significant predictors for advanced OIs occurrence. Children who were low hemoglobin level of adherence were nearly 2 times [AHR: 1.6, 95% CI: 1.1, 3.3] a higher risk of developing advanced OIs as compared to the counterpart (Table 3) . This study revealed that the median advanced OIs free survival time was 113 months and the overall incidence rate was 5.3 100 person-years among HIV infected children at Debre Tabor referral hospital and University of Gondar Compressive specialized hospital was 5.3 100 personyears. The incidence of advanced OIs in this study was comparable to the study conducted in the United States of America and meta-analysis in middle and low income countries [31, 32] . However, the incidence of advanced OIs found by this study is lower than the study conducted in Asia (10.5 per 100 person-years) and Ethiopia (9.7 per 100 person-years) [7, 17] . This could be due to the difference in outcome variable criteria. In the above mentioned studies were taking all types of OIs, whereas this study is only advanced OIs. Another explanation may be the differences in follow-up periods, sample size, and study setting. On the other hand, the incidence of advanced OIs found by this study is higher than the study conducted in Brazil (2.63 per 100 person-years) and Latin America (1.1 per 100 person-years) [18, 33] . The reason for this might be due to the difference in follow-up periods, outcome variable criteria, and study population including adults and children. Moreover, this difference could be due to middle income countries having good healthcare service as compared with resource limited settings like Ethiopia, which can reduce the incidence of advanced OIs. Pneumonia is the most common (35.6%) during the follow-up time. This finding is consistent with a study conducted in North America, Latin North America, and China [32, 34, 35, 36] . In contrast, a study conducted in Ethiopia and India revealed that TB is a common opportunistic infection [17, 37] . Besides, chronic diarrhea greater than 01 months, which accounts for 10.34% of all types of advanced OIs in this study. This is also a significant finding that hasn't been reported in other studies. Children who were poor/fair level adherence to ART were nearly 2 times more at risk of advanced OIs than those children who were at good level of adherence. This result is consistent with the study conducted in Brazil, Ethiopia, and Cameron [14, 17, 38] . This finding is likely due to the fact that doesn't take ART proper (i.e., poor/fair level of ART) can reduce the higher risk for Advanced OIs and different comorbidity illnesses associated with HIV. Moreover, poor/fair level of ART leading to drug resistance and mortality [38] . Children who were CPT non-user were nearly 2 times more likely to develop advanced OIs as compared to those children with CPT users. This finding is consistent with studies done in Zambia and Ethiopia [9, 17] . This is due to the fact that the main purpose of CPT supplementation is to prevent opportunistic infections associated with HIV. Children presenting with a low hemoglobin level (10 mg/dl) had a higher risk of developing advanced OIs nearly by three-fold, which is consistent with other studies in Nigeria and Uganda [39, 40] . Besides, children presenting with treatment failure had a higher risk of developing advanced OIs nearly by two-fold. Surprisingly, an IPT non-user and low CD4þ cell count below the threshold level didn't associate with the occurrence of advanced OIs in this study. In the above mentioned predictor variables (i.e., failure, CPT, nonuser, low hemoglobin, and poor/fair level of ART adherence) were less advanced OIs free survival time as compared with their counterparts. The advanced OIs free survival times of children with treatment failure were less free survival time 45 months as compared with hadn't treatment failure history 129 months. Besides, children who were CPT non-user were less advanced OIs free survival time 71 months as compared with CPT users 113 months. Children presenting with good level adherence were higher advanced OIs free survival time 115 as compared with children with poor/fair level ART adherence. Likewise, and children who had hemoglobin level !10 mg/dl were higher advanced OIs free survival time 129 as compared with their counterparts 42 months. This is a new significant finding that hasn't been reported in the previous studies era. Hence, prevention and treatment of anemia, treatment failure, and poor/ fair level of adherence are pivotal to reduce the incidence of advanced OIs. Alongside, cotrimoxazole preventive therapy supplementation for all children with HIV is the best strategies to reduce the burden of advance OIs. This study is a multicenter with a long (ten-year) follow-up period study. However, some other confounders could affect our results such hygienic practice of the community with awareness level of patients and their caregiver, and easy access to appropriate medical services. Additionally, the data were collected retrospectively or from secondary data, writing bias or bias from interpretation from the medical records may have happened, which might be an underestimated incidence rate of advanced OIs. In this study, the median of advanced OIs free survival time was found to be low and the incidence rate was found to be high. The incidence advanced OIs was associated with anemia, treatment failure, and poor/ fair level of adherence, cotrimoxazole preventive therapy non-users. Further research should conduct to evaluate and to improve the quality of care in the study setting. Ermias Sisay Chanie: Conceived and designed the experiments; Wrote the paper. Wubet Alebachew Bayih, Binyam Minuye Birhan, Demeke Mesfin Belay, Getnet Asmare, Tegenaw Tiruneh, Yared Asmare Aynalem Aynalem, Biruk Beletew Abat, Sintayehu Asnakew Alemayehu, Maru Mekie, Getache Yideg Yitbarek and Fisha Alebel GebreEyesus: Analyzed and interpreted the data; Contributed reagents, materials, analysis tools or data; Wrote the paper. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. Data included in article/supplementary material/referenced in article. The authors declare no conflict of interest. No additional information is available for this paper. What is an opportunistic infection? Opportunistic infections | living with HIV | HIV basics | HIV/AIDS | CDC Global HIV & AIDS statistics -2020 fact sheet Common opportunistic infections in HIV infected infants and children Part 1-respiratory infections Current trends in opportunistic infections in children living with HIV/AIDS in a tertiary care hospital in Northern India Impact of antiretroviral therapy on opportunistic infections of HIVinfected children in the TREAT Asia pediatric HIV observational database Natural history of HIV infection in the_era of combination antiretroviral therapy Cotrimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada Life expectancy living with HIV: recent estimates and future implications Trends in AIDS-defining opportunistic illnesses incidence over 25 Years in rio de Janeiro, Brazil Disparities in the magnitude of human immunodeficiency virusrelated opportunistic infections between high and low/middle-income countries: is highly active antiretroviral therapy changing the trend? Prevention of opportunistic infections in HIV Incidence of common opportunistic infections among HIVinfected children on ART at Debre Markos referral hospital, Northwest Ethiopia: a retrospective cohort study Impact of highly active antiretroviral therapy (HAART) on the incidence of opportunistic infections, hospitalizations and mortality among children and adolescents living with HIV/AIDS in Belo Horizonte Incidence of opportunistic infections and the impact of antiretroviral therapy among HIV-infected adults in low-and middle-income countries: a systematic review and meta-analysis Understanding the contribution of common childhood illnesses and opportunistic infections to morbidity and mortality in children living with HIV in resource-limited settings Magnitude of opportunistic infections and associated factors in HIV-infected adults on antiretroviral therapy in eastern Ethiopia Prevalence and predictors of opportunistic infections among HIV positive adults on antiretroviral therapy (On-ART) versus pre-ART in Addis Ababa, Ethiopia: a comparative cross-sectional study Central nervous system viral invasion and inflammation during acute HIV infection HIV/AIDS risks as a consequence of schizophrenia The immune system of children: the key to understanding SARS-CoV-2 susceptibility? Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study Predictors of treatment failure on second-line antiretroviral therapy among adults in northwest Ethiopia: a multicentre retrospective follow-up study Guidelines for Paediatric HIV/AIDS Care and Treatment in Ethiopia National Guidelines for HIV/AIDS and Nutrition Guidelines for Paediatric HIV/AIDS Care and Treatment in Ethiopia Incidence and prevalence of opportunistic and other infections and the impact of antiretroviral therapy among HIV-infected children in low-and middle-income countries: a systematic review and meta-analysis Risk factors for opportunistic illnesses in children with human immunodeficiency virus in the era of highly active antiretroviral therapy Trends in opportunistic infections in the pre-and post-highly active antiretroviral therapy eras among HIV-infected children in the perinatal AIDS collaborative transmission study Incidence of opportunistic and other infections in HIV-infected children in the HAART era Opportunistic and other infections in HIV-infected children in Latin America compared to a similar cohort in the United States Spectrum of opportunistic infections and risk factors for in-hospital mortality of admitted AIDS patients in shanghai Opportunistic infections in HIV infected children and its correlation with CD4 count Adherence to antiretroviral therapy (ART) in yaound e-Cameroon: association with opportunistic infections, depression, ART regimen and side effects Ten years of antiretroviral therapy: incidences, patterns and risk factors of opportunistic infections in an urban Ugandan cohort Prevalence and risk factors for opportunistic infections in HIV patients receiving antiretroviral therapy in a resource-limited setting in Nigeria We would like to thank the Debre Tabor referral hospital and University of Gondar compressive specialized hospital administrative bodies. Likewise, our thanks also go to all individuals who participated in data collectors and supervisors.